For the treatment of bacterial keratitis, adjunctive corticosteroids are not superior to placebo and adjunctive corneal cross-linking (CXL) is associated with increased scar size, according to a study ...

NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) (the “Company”), and a clinical stage, leading global ...

Cycle Pharmaceuticals announced the launch of HARLIKU, the first and only FDA-approved treatment for reducing urinary ...

The best pet insurance policies for French and English bulldogs, pugs, Boston terriers, Shih Tzus and other brachycephalic ...

KB801 is a redosable eye drop gene therapy in development for the treatment of NK, a degenerative corneal disease characterized by damage or loss of function in the neurons innervating the eye ...

Shoppers with dry skin are raving about Nécessaire’s Body Serum after it intensely hydrated their body and healed keratosis pilaris. Add the shopper-loved product to your body care routine for $48 at ...

Trial evaluated number of supplemental injections needed for the treatment of DME for patients on ILUVIEN versus the ...

Any statements in this press release about future expectations, plans and prospects for Krystal Biotech, Inc.’s product candidate, KB801, and its EMERALD-1 clinical trial evaluating KB801 for the ...

Butt acne is a term used to describe small, red bumps on the buttocks. However, it is not the same acne that affects the face ...

The market is set to reach USD 1.69 billion by 2035, growing at a 5.2% CAGR from its 2025 valuation of USD 1.01 billion. This ...

SHELTON, CT / ACCESS Newswire / July 21, 2025 / NanoViricides, Inc., a publicly traded company (NYSE Amer.: NNVC ) (the ...

The reimbursement approval for AKANTIOR is a major step forward, bringing new hope for patients with AK in Spain and more confidence to ophthalmologists who care for them said Dr. Ana Hervás Ontiveros ...